| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
|
|
2010
|
50 |
9 |
p. 1058-1095
|
artikel
|
| 2 |
ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics
|
Brundage, Richard C.
|
|
2010
|
50 |
9 |
p. 7S-8S
|
artikel
|
| 3 |
Antiviral Information Management System (AIMS): A Prototype for Operational Innovation in Drug Development
|
Jadhav, Pravin R.
|
|
2010
|
50 |
9 |
p. 50S-55S
|
artikel
|
| 4 |
A Proof-of-Concept and Drug-Drug Interaction Study of Pamapimod, a Novel p38 MAP Kinase Inhibitor, With Methotrexate in Patients With Rheumatoid Arthritis
|
Xiaoping Zhang,
|
|
2010
|
50 |
9 |
p. 1031-1038
|
artikel
|
| 5 |
Bridging Pharmacology and Pathophysiology via Systems Modeling
|
D'Argenio, David Z.
|
|
2010
|
50 |
9 |
p. 56S-57S
|
artikel
|
| 6 |
Defining the Future of Pharmacometrics: The American Society of Pharmacometrics
|
Pfister, Marc
|
|
2010
|
50 |
9 |
p. 158S-158S
|
artikel
|
| 7 |
Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers
|
Bergman, Ebba
|
|
2010
|
50 |
9 |
p. 1039-1049
|
artikel
|
| 8 |
Effects of the Peroxisome Proliferator Activated Receptor-γ Coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser Polymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus
|
Zhang, Ke-Han
|
|
2010
|
50 |
9 |
p. 1022-1030
|
artikel
|
| 9 |
Evaluation and Recommendations on Adaptive Dose-Ranging Trials: Highlights From the PhRMA Adaptive Dose-Ranging Studies Working Group
|
Pinheiro, José
|
|
2010
|
50 |
9 |
p. 47S-49S
|
artikel
|
| 10 |
Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis
|
Doshi, Sameer
|
|
2010
|
50 |
9 |
p. 75S-90S
|
artikel
|
| 11 |
Fostering Culture and Optimizing Organizational Structure for Implementing Model-Based Drug Development
|
Liping Zhang,
|
|
2010
|
50 |
9 |
p. 146S-150S
|
artikel
|
| 12 |
Interactive Visualization and Communication for Increased Impact of Pharmacometrics
|
Krause, Andreas
|
|
2010
|
50 |
9 |
p. 140S-145S
|
artikel
|
| 13 |
Is There an Association Between 5-Azacitidine and Ototoxicity?
|
Malik, Afshan
|
|
2010
|
50 |
9 |
p. 1056-1057
|
artikel
|
| 14 |
Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers
|
Ermer, James
|
|
2010
|
50 |
9 |
p. 1001-1010
|
artikel
|
| 15 |
Missing Data in Model-Based Pharmacometric Applications: Points to Consider
|
Gastonguay, Marc R.
|
|
2010
|
50 |
9 |
p. 63S-74S
|
artikel
|
| 16 |
Model-Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development
|
Wetherington, Jeffrey D.
|
|
2010
|
50 |
9 |
p. 31S-46S
|
artikel
|
| 17 |
Model-Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry
|
Stone, Julie A.
|
|
2010
|
50 |
9 |
p. 20S-30S
|
artikel
|
| 18 |
Models for Event-Driven Data: Longitudinal Daily Adverse Event and Dropout
|
Miller, Raymond
|
|
2010
|
50 |
9 |
p. 58S-62S
|
artikel
|
| 19 |
Pharmacometrics 2020
|
Gobburu, Jogarao V. S.
|
|
2010
|
50 |
9 |
p. 151S-157S
|
artikel
|
| 20 |
Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success
|
Romero, Klaus
|
|
2010
|
50 |
9 |
p. 9S-19S
|
artikel
|
| 21 |
Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations
|
Krzyzanski, Wojciech
|
|
2010
|
50 |
9 |
p. 101S-112S
|
artikel
|
| 22 |
Population Pharmacokinetic-Pharmacodynamic Modeling of Biological Agents: When Modeling Meets Reality
|
Mould, Diane R.
|
|
2010
|
50 |
9 |
p. 91S-100S
|
artikel
|
| 23 |
Review: Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban
|
Morell, Jason
|
|
2010
|
50 |
9 |
p. 986-1000
|
artikel
|
| 24 |
Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
|
Thyssen, An
|
|
2010
|
50 |
9 |
p. 1011-1021
|
artikel
|
| 25 |
Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism-Based Model Characterizing Sodium—Glucose Cotransporter-2 Inhibition
|
Liping Zhang,
|
|
2010
|
50 |
9 |
p. 113S-120S
|
artikel
|
| 26 |
The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy
|
Overton, Edgar T.
|
|
2010
|
50 |
9 |
p. 1050-1055
|
artikel
|
| 27 |
The Emerging Scientific Discipline of Pharmacometrics
|
Pfister, Marc
|
|
2010
|
50 |
9 |
p. 6S-6S
|
artikel
|
| 28 |
The Need for Modeling and Simulation to Design Clinical Investigations in Children
|
Jadhav, Pravin R.
|
|
2010
|
50 |
9 |
p. 121S-129S
|
artikel
|
| 29 |
Visualization Concepts to Enhance Quantitative Decision Making in Drug Development
|
Dykstra, Kevin
|
|
2010
|
50 |
9 |
p. 130S-139S
|
artikel
|
Tijdschrift beschrijving